- Active not recruiting
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
This study looks back at French health records to understand how different blood-thinning medicines affect people with an irregular heartbeat (atrial fibrillation) who are at higher risk of stomach bleeding. It compares older medicines like warfarin with newer ones to see how safe and effective they are.
For: Atrial FibrillationUnited Kingdom - Active not recruiting
Anticoagulation in Patients With Venous Thromboembolism and Cancer
This study looks back at patient records to understand how different blood-thinning medicines work for people with cancer who have also had blood clots. It compares medicines like Apixaban, Rivaroxaban, and Dabigatran to see which are most effective and safe.
For: Neoplasms · EmbolismUnited Kingdom - RecruitingPHASE4
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
This study compares different blood thinners (Dabigatran vs. Apixaban, Edoxaban, or Rivaroxaban) in people with a serious স্টাফ infection (S. aureus bacteremia). We want to see if switching to dabigatran, which might fight the infection, improves outcomes for patients already taking blood thinners.
For: Staphylococcus Aureus Endocarditis · Staphylococcus Aureus Septicemia · Staphylococcus Aureus BacteremiaCanada